The influencing factors of RLM. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. This effect remains significant after a series of robustness checks. …”

Variable definitions and basic statistics. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. This effect remains significant after a series of robustness checks. …”

Average and marginal effects of RLM on HWSW. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. This effect remains significant after a series of robustness checks. …”

Channel pruning process. by Zhongjian Xie (4633099)

“…<p>After channel pruning, the algorithm model experiences a significant reduction in parameters and computational load, yet it may incur a decrease in accuracy. …”

Interpretation of findings of the present study. by Rayane Brinck Teixeira (6676529)

Occurrence of subcortical immature neurons (scINs) in the amygdala of mouse and primates: relationship with evolution of subnuclei scaling and cortical connectomics. by Marco Ghibaudi (16701750)

Heterotrophic cell growth and dry cell yield of <i>Rhodovulum sulfidophilum</i> in artificial seawater (ASW) based growth medium of different salinities, wherein 100% corresponds t... by Shamitha Rao Morey-Yagi (19779981)

Data Sheet 1_A home-based EEG neurofeedback treatment for chronic neuropathic pain—a pilot study.docx by Mohamed Sakel (9416397)

“…Mood scores showed a significant decrease in depression (p < 0.05), and pain catastrophizing (p < 0.05) scores improved significantly at post-intervention, with continued improvement at the first-month follow-up.…”

Raw data underlying the findings in this study. by Andrew Mvula (20161161)

“…The relative bone density significantly decreased as standard length and condition factor (<i>K</i>) increased in both sexes. …”

S1 File - by Zsófia Tróznai (19923854)

“…Body size, body composition, and maturity had a significant, but of moderate power, effect on the selection. …”

Flowchart of the selection program. by Zsófia Tróznai (19923854)

“…Body size, body composition, and maturity had a significant, but of moderate power, effect on the selection. …”

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data from: Quantifying seed rain patterns in a remnant and a chronosequence of restored tallgrass prairies in north central Missouri by Katherine Wynne (22078346)

“…We also found that seed rain patterns changed as prairies aged, with each prairie possessing a distinct community of dispersing species. Significantly more seeds, seed biomass, and species were captured in the youngest restored prairie. …”

Map showing the intervention and control LGAs. by Chinwe C. Eze (8787503)

“…To address this gap, effectiveness of combined leprosy and BU self-help groups (SHGs) on stigma reduction was assessed as part of a larger randomized controlled study.</p><p>Methodology/principal findings</p><p>A cluster randomized study was conducted in Southern Nigeria from 2021 to 2023. …”

Consort diagram. by Chinwe C. Eze (8787503)

“…To address this gap, effectiveness of combined leprosy and BU self-help groups (SHGs) on stigma reduction was assessed as part of a larger randomized controlled study.</p><p>Methodology/principal findings</p><p>A cluster randomized study was conducted in Southern Nigeria from 2021 to 2023. …”

Table 1_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

“…Based on these preliminary findings, future studies with larger samples are warranted to determine the extent to which domain-general IC performance associated with fronto-cortico-striatal IC circuit activation contributes to the alcohol use pathophysiology, and whether therapeutic interventions (e.g., non-invasive brain stimulation) targeting fronto-cortico-striatal IC circuitry may decrease AUD symptomatology.…”